Daniel Kenny

Biography

 Daniel Kenny has been appointed as Chief Executive Officer, Director of OncoSil Medical Limited., effective 5 January 2015. He has been appointed to the position of Director of the Company effect from 28 November 2014. Mr Kenny is a highly experienced and successful biopharmaceutical sector professional, with almost 30 years' experience in the global pharmaceutical industry, including senior roles with Roche, Allergan and Baxter. He also has more than 10 years experience in clinical research in the fields of ophthalmology and HIV/AIDS prior to join the pharmaceutical industry. Prior to joining OncoSil, Mr Kenny was Chief Commercial Officer and Vice President Business Development at major French biopharmaceutical company, ABIVAX, where he was responsible for the development and implementation of the commercial and business development strategy. He was also previously Global Franchise Head at Baxter Vaccines, where he successfully reinvigorated the base commercial business and significantly exceeded the business’s financial plan in each of the three years of his tenure. Mr Kenny was also Vice President Baxter BioScience, EMEA where he was responsible for the marketing and key business programmes in support of regional sales exceeding $1.9 billion. Amongst other roles, Mr Kenny has also been Global LifeCycle Leader for Roaccutane with Roche. He was responsible for global strategic marketing and business development activities for Roaccutane, an acne treatment product, which generated sales in excess of CHF1.1 billion in 2002. Mr Kenny is a graduate in Physics from the University of New South Wales and has completed Executive business studies at INSEAD and the London Business School.

Research Interest

 pharmaceutical sciences business and dveloopment